Previous 10 | Next 10 |
home / stock / tevjf / tevjf news
Summary Calamos offers seven different closed-end funds, all with some overlap. CHY and CHI seem to have the most overlap of the group. Today, we are looking at just how similar they are and deciding if either is a better deal at this time. Written by Nick Ackerman, co...
Summary Teva Pharmaceutical's divestments have been many in recent years, and the company presents a different set-up than in the past. In about 5 years Teva Pharmaceutical has reduced its net debt by $14 billion, a remarkable sum for a company with a market cap of only $10 billio...
Summary Viatris's total revenue was $4,116.8 million in Q2 2022, down 10.1% year-on-year. Sales of the company's branded medicines have been declining since the formation of Viatris in 2020. The company has a dividend yield of 5.08%, but dividend payouts are at risk from 2026....
Pfizer's net income was $7,864 million in Q2 2022, up 131.8% QoQ. AbbVie's net income was $924 million in Q2 2022, up 20.6% year-on-year. It is unlikely that the Inflation Reduction Act will have a strong impact on the financial position of Pfizer and AbbVie. Both companies ha...
David Abrams’ 13F portfolio value decreased this quarter from $4.28B to $3.72B. The number of positions remained steady at 18. The portfolio was untouched this quarter. The top three positions are Lithia Motors, Change Healthcare, and Asbury Automotive. They add up to ~38% ...
Teva Pharmaceutical's revenue was $3,786 million in Q2 2022, up 3.4% QoQ. The company's total debt continues to decline quarter on quarter and stands at $22,453 million at the end of Q2 2022. Teva Pharmaceutical has made progress in resolving opioid crisis lawsuits, reaching an ag...
During the second quarter of 2022, the Miller Opportunity Trust – Class I shares generated a total return of -29.45% excluding sales charges. Using a three-factor performance attribution model, selection, allocation and interaction effects contributed to the portfolio’s ...
Teva Pharmaceutical Industries Limited (TEVA) Q2 2022 Earnings Conference Call July 27, 2022 8:00 AM ET Company Participants Ran Meir – Senior Vice President, Head of Investor Relations Kare Schultz – Chief Executive Officer Eli Kalif – Chief...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2022 Q2 earnings call. For further details see: Teva Pharmaceutical Industries Limited 2022 Q2 - Results - Earnings Call Presentation
Miller Value Partners is a value investor. It values businesses, and not just stocks, and invests in them for the long term. Miller Opportunity Equity was down 31.8% net of fees in first half. We see many compelling opportunities we think can do well irrespective of the macro. ...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Ltd Company Name:
TEVJF Stock Symbol:
OTCMKTS Market:
Teva Pharmaceutical Industries Ltd Website: